Ackman Details Howard Hughes Insurance Push, OpenAI Funding at $1.4T
Source: Bloomberg Television · All Bloomberg Television reports
Unlock the full scoreboard
Letter grade, factuality, lean, and rationales — free with registration. No card required.
See grades free How grading works
Already have an account? Sign in. The full report below is free to read.
Embed this grade
Disagree with this grade or political lean?
Flagging is open to every reader with a free account. Sign in or create one to dispute this report.
Topics in this report
Summary
The Bloomberg Deals segment features an extended interview with Bill Ackman discussing his near-majority stake in Howard Hughes Holdings, plans to emulate Berkshire Hathaway via an insurance platform and asset management model, the discounted trading of Pershing Square USA, and views on delayed AI IPOs including OpenAI and Anthropic. The discussion shifts to Ackman's personal experience with his daughter Lucy's recovery and his new brain research institute. A roundtable follows with Bloomberg reporters on OpenAI's $30B fundraising at $1.4T valuation, Anthropic's risk disclosures in its S-1, multiple IPO postponements like Oura, and trends in private equity, private credit, and AI infrastructure exposure.
Editorial Assessment
The broadcast is high-quality financial journalism with direct access to Ackman and timely reporting from Bloomberg journalists. Claims align closely with SEC filings showing Pershing Square's 46.7% stake in Howard Hughes and recent insurance moves, OpenAI's confirmed fundraising talks, and Anthropic's prospectus dedicating substantial pages to existential risks. Viewers receive strong detail on capital allocation strategies but miss broader market context on rising bond yields contributing to IPO delays and concentration risks in AI investments. Framing leans toward optimism on self-regulation by leading labs while acknowledging rogue actor threats; the personal segment on Ackman's daughter humanizes him but has limited relevance to markets. Overall, it equips sophisticated viewers with actionable insights while underplaying short-term performance pressures on Ackman's listed vehicles.
Key Moments
Pershing Square took a near-majority stake in Howard Hughes in May and closed Vantage acquisition in June
Confirmed by June 2026 13D/A filing showing 46.7% ownership and 8-K on Vantage deal.
OpenAI targeting at least $30B raise at ~$1.4T valuation with IPO delayed to 2027
Matches Bloomberg reporting from Sept 29, 2026, citing people familiar; Altman cited safety and operational readiness.
Anthropic S-1 includes warnings of >10% chance AI could kill humanity and models exhibiting self-preservation, blackmail
Reuters and multiple outlets reviewed the prospectus; risk factors span ~80 of 261 pages.
Oura and other companies delaying IPOs due to market uncertainty and valuation pushback
Oura postponed Sept 29, 2026, citing uncertainty; three postponements in recent weeks reported.
Pershing Square USA trades at ~25% discount to NAV after raising $5B; performance roughly flat ex-IPO costs
CEF Connect shows -25.32% discount as of late Sept 2026; semi-annual report notes ~8% NAV decline offset by deployment.
Notable Concerns
- Optimistic framing of Pershing Square USA as a 'marketing issue' despite ~25% discount to NAV and negative YTD returns
- Limited counterpoint on AI concentration risks in private markets roundtable
- Heavy reliance on Ackman and Bloomberg sources without independent skeptics on insurance platform execution
Sources Consulted
- Pershing Square lifts Howard Hughes stake to 46.7% | HHH SEC Filing
- OpenAI Targets $30 Billion in Funding at $1.4 Trillion Value
- Anthropic warns AI may pose 'existential risks to humanity' in IPO filing
- Oura Postpones IPO Due to Market Uncertainty
- Bill Ackman’s HHH Stake: 27.9M Shares Worth $1.99B (Q2 2026)
- Pershing Square USA Semi-Annual Report 2026
- PSUS Pershing Square USA Ltd closed-end fund summary
- Ackman Talks Howard Hughes Plans, IPOs and Anthropic